Patient received 2 doses of RSV. 1st dose administered was Arexvy 2023 and 2nd dose was Abrysvo 2025. Patient reports no adverse effects
Patient received 2 doses of RSV. 1st dose administered was Arexvy 2023 and 2nd dose was Abrysvo 2025. Patient reports no adverse effects